{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:42:10Z","timestamp":1786376530119,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Thyroid cancer encompasses distinct histological subtypes, each potentially associated with unique metabolic characteristics. However, the comprehensive metabolic reprogramming underlying these malignancies remains insufficiently characterized. Hence, this study aimed to identify untargeted metabolomics alterations in plasma samples from patients diagnosed with papillary thyroid carcinoma (PTC), follicular thyroid carcinoma (FTC), medullary thyroid carcinoma (MTC), and healthy controls, to elucidate potential metabolic signatures associated with each cancer type.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Plasma samples from patients with PTC (<jats:italic>n<\/jats:italic>\u2009=\u200914), FTC (<jats:italic>n<\/jats:italic>\u2009=\u20098), and MTC (<jats:italic>n<\/jats:italic>\u2009=\u200915), along with samples from healthy subjects (<jats:italic>n<\/jats:italic>\u2009=\u200915), were collected for untargeted metabolomics analysis using gas chromatography-mass spectrometry (GC\/MS). Multivariate and univariate analyses were performed for diagnostic assessment using MetaboAnalyst, SIMCA software, and R packages.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 61 metabolites were annotated across all plasma samples. Multivariate analyses, including partial least squares discriminant analysis (PLS-DA) and orthogonal PLS-DA (OPLS-DA), revealed distinct group separations and demonstrated robust model performance. One-way ANOVA followed by Tukey\u2019s HSD and variable importance in projection (VIP\u2009\u2265\u20091) highlighted 35 significantly altered metabolites. Among these, linolenic acid (<jats:italic>q<\/jats:italic>\u2009=\u20094.76E-13) and arachidonic acid (<jats:italic>q<\/jats:italic>\u2009=\u20091.39E-12) showed substantial reductions across all thyroid cancer subtypes. Conversely, glutamine (<jats:italic>q<\/jats:italic>\u2009=\u20091.14E-10), methionine (<jats:italic>q\u2009<\/jats:italic>=\u20092.54E-09), and 2-hydroxybutanoic acid (<jats:italic>q<\/jats:italic>\u2009=\u20091.49E-07) were elevated in FTC and PTC. A Random Forest analysis further highlighted linolenic, linoleic, arachidonic acids, methionine, glutamine, and pyruvic acid, as crucial discriminative elements, achieving a macro-averaged AUC of 0.956 in multi-class classification.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This plasma metabolomics study reveals distinctive metabolic signatures associated with different thyroid cancer subtypes, suggesting potential biomarkers for differential diagnosis. These findings underscore the importance of metabolomics in enhancing subtype differentiation and provide insight into metabolic pathways associated with disease progression.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12885-025-15073-0","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T09:56:39Z","timestamp":1760522199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Metabolomics fingerprinting of thyroid malignancies: a GC\/MS-based approach for subtype classification and biomarker discovery"],"prefix":"10.1186","volume":"25","author":[{"given":"Raziyeh","family":"Abooshahab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Zarkesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Hedayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"issue":"1","key":"15073_CR1","doi-asserted-by":"publisher","first-page":"8397","DOI":"10.1038\/s41598-022-12590-x","volume":"12","author":"MG Jajin","year":"2022","unstructured":"Jajin MG, Abooshahab R, Hooshmand K, Moradi A, Siadat SD, Mirzazadeh R, et al. Gas chromatography-mass spectrometry-based untargeted metabolomics reveals metabolic perturbations in medullary thyroid carcinoma. Sci Rep. 2022;12(1):8397.","journal-title":"Sci Rep"},{"issue":"1","key":"15073_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","volume":"33","author":"ZW Baloch","year":"2022","unstructured":"Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, et al. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol. 2022;33(1):27\u201363.","journal-title":"Endocr Pathol"},{"key":"15073_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/modpathol.2010.129","volume":"24","author":"VA LiVolsi","year":"2011","unstructured":"LiVolsi VA. Papillary thyroid carcinoma: an update. Mod Pathol. 2011;24:S1\u20139.","journal-title":"Mod Pathol"},{"issue":"1","key":"15073_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ecl.2018.11.006","volume":"48","author":"D Viola","year":"2019","unstructured":"Viola D, Elisei R. Management of medullary thyroid cancer. Endocrinol Metab Clin. 2019;48(1):285\u2013301.","journal-title":"Endocrinol Metab Clin"},{"issue":"11","key":"15073_CR5","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1089\/thy.2012.0302","volume":"22","author":"RC Smallridge","year":"2012","unstructured":"Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD, et al. American thyroid association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2012;22(11):1104\u201339.","journal-title":"Thyroid"},{"issue":"11","key":"15073_CR6","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.3390\/metabo12111154","volume":"12","author":"R Abooshahab","year":"2022","unstructured":"Abooshahab R, Ardalani H, Zarkesh M, Hooshmand K, Bakhshi A, Dass CR, et al. Metabolomics\u2014a tool to find metabolism of endocrine cancer. Metabolites. 2022;12(11):1154.","journal-title":"Metabolites"},{"issue":"1","key":"15073_CR7","first-page":"8095378","volume":"2020","author":"B Anand","year":"2020","unstructured":"Anand B, Ramdas A, Ambroise MM, Kumar NP. The bethesda system for reporting thyroid cytopathology: a cytohistological study. J Thyroid Res. 2020;2020(1):8095378.","journal-title":"J Thyroid Res"},{"issue":"Supplement 1","key":"15073_CR8","first-page":"81","volume":"59","author":"J Lukinovi\u0107","year":"2020","unstructured":"Lukinovi\u0107 J, Bili\u0107 M. Overview of thyroid surgery complications. Acta Clin Croat. 2020;59(Supplement 1):81\u20136.","journal-title":"Acta Clin Croat"},{"issue":"6487","key":"15073_CR9","doi-asserted-by":"publisher","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368(6487):eaaw5473.","journal-title":"Science"},{"issue":"2","key":"15073_CR10","doi-asserted-by":"publisher","first-page":"113936","DOI":"10.1016\/j.yexcr.2024.113936","volume":"435","author":"R Abooshahab","year":"2024","unstructured":"Abooshahab R, Razavi F, Ghorbani F, Hooshmand K, Zarkesh M, Hedayati M. Thyroid cancer cell metabolism: a glance into cell culture system-based metabolomics approaches. Exp Cell Res. 2024;435(2):113936.","journal-title":"Exp Cell Res"},{"key":"15073_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12020-019-01904-1","volume":"65","author":"R Abooshahab","year":"2019","unstructured":"Abooshahab R, Gholami M, Sanoie M, Azizi F, Hedayati M. Advances in metabolomics of thyroid cancer diagnosis and metabolic regulation. Endocrine. 2019;65:1\u201314.","journal-title":"Endocrine"},{"key":"15073_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3389\/fcell.2020.00385","volume":"8","author":"R Abooshahab","year":"2020","unstructured":"Abooshahab R, Hooshmand K, Razavi SA, Gholami M, Sanoie M, Hedayati M. Plasma metabolic profiling of human thyroid nodules by gas chromatography-mass spectrometry (GC-MS)-based untargeted metabolomics. Front Cell Dev Biol. 2020;8:385.","journal-title":"Front Cell Dev Biol"},{"issue":"49","key":"15073_CR13","doi-asserted-by":"publisher","first-page":"81768","DOI":"10.18632\/oncotarget.13178","volume":"7","author":"J Lu","year":"2016","unstructured":"Lu J, Hu S, Miccoli P, Zeng Q, Liu S, Ran L, et al. Non-invasive diagnosis of papillary thyroid microcarcinoma: a NMR-based metabolomics approach. Oncotarget. 2016;7(49):81768.","journal-title":"Oncotarget"},{"issue":"8","key":"15073_CR14","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/metabo15080514","volume":"15","author":"A Elguoshy","year":"2025","unstructured":"Elguoshy A, Zedan H, Saito S. Machine learning-driven insights in cancer metabolomics: from subtyping to biomarker discovery and prognostic modeling. Metabolites. 2025;15(8):514.","journal-title":"Metabolites"},{"issue":"8","key":"15073_CR15","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1194\/jlr.R120000800","volume":"61","author":"T Harayama","year":"2020","unstructured":"Harayama T, Shimizu T. Roles of polyunsaturated fatty acids, from mediators to membranes. J Lipid Res. 2020;61(8):1150\u201360.","journal-title":"J Lipid Res"},{"issue":"6","key":"15073_CR16","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1093\/ajcn\/84.6.1277","volume":"84","author":"SR Shaikh","year":"2006","unstructured":"Shaikh SR, Edidin M. Polyunsaturated fatty acids, membrane organization, T cells, and antigen presentation. Am J Clin Nutr. 2006;84(6):1277\u201389.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"15073_CR17","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2125.2012.04374.x","volume":"75","author":"PC Calder","year":"2013","unstructured":"Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol. 2013;75(3):645\u201362.","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"15073_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.molmed.2008.08.005","volume":"14","author":"H Harizi","year":"2008","unstructured":"Harizi H, Corcuff J-B, Gualde N. Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends Mol Med. 2008;14(10):461\u20139.","journal-title":"Trends Mol Med"},{"issue":"11","key":"15073_CR19","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","volume":"34","author":"M Martin-Perez","year":"2022","unstructured":"Martin-Perez M, Urdiroz-Urricelqui U, Bigas C, Benitah SA. The role of lipids in cancer progression and metastasis. Cell Metab. 2022;34(11):1675\u201399.","journal-title":"Cell Metab"},{"key":"15073_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-6614-4-3","volume":"4","author":"K Krawczyk-Rusiecka","year":"2011","unstructured":"Krawczyk-Rusiecka K, Wojciechowska-Durczy\u0144ska K, Cyniak-Magierska A, Adamczewski Z, Ga\u0142ecka E, Lewi\u0144ski A. COX-2 expression in papillary thyroid carcinoma (PTC) in cytological material obtained by fine needle aspiration biopsy (FNAB). Thyroid Res. 2011;4:1\u20136.","journal-title":"Thyroid Res"},{"key":"15073_CR21","doi-asserted-by":"publisher","first-page":"682269","DOI":"10.3389\/fcell.2021.682269","volume":"9","author":"N Jiang","year":"2021","unstructured":"Jiang N, Zhang Z, Chen X, Zhang G, Wang Y, Pan L, et al. Plasma lipidomics profiling reveals biomarkers for papillary thyroid cancer diagnosis. Front Cell Dev Biol. 2021;9:682269.","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"15073_CR22","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.phrs.2006.03.009","volume":"53","author":"D Langin","year":"2006","unstructured":"Langin D. Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol Res. 2006;53(6):482\u201391.","journal-title":"Pharmacol Res"},{"key":"15073_CR23","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/s11306-014-0643-0","volume":"10","author":"AM Mondul","year":"2014","unstructured":"Mondul AM, Moore SC, Weinstein SJ, M\u00e4nnist\u00f6 S, Sampson JN, Albanes D. 1-stearoylglycerol is associated with risk of prostate cancer: results from a serum metabolomic profiling analysis. Metabolomics. 2014;10:1036\u201341.","journal-title":"Metabolomics"},{"issue":"12","key":"15073_CR24","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1530\/ERC-19-0344","volume":"26","author":"J Chen","year":"2019","unstructured":"Chen J, Hu Q, Hou H, Wang S, Zhang Y, Luo Y, et al. Metabolite analysis-aided diagnosis of papillary thyroid cancer. Endocrine-related Cancer. 2019;26(12):829\u201341.","journal-title":"Endocrine-related Cancer"},{"key":"15073_CR25","doi-asserted-by":"publisher","first-page":"593510","DOI":"10.3389\/fcell.2021.593510","volume":"9","author":"Y Du","year":"2021","unstructured":"Du Y, Fan P, Zou L, Jiang Y, Gu X, Yu J, et al. Serum metabolomics study of papillary thyroid carcinoma based on HPLC-Q-TOF-MS\/MS. Front Cell Dev Biol. 2021;9:593510.","journal-title":"Front Cell Dev Biol"},{"issue":"5930","key":"15073_CR26","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029\u201333.","journal-title":"Science"},{"issue":"6","key":"15073_CR27","first-page":"1017","volume":"17","author":"S Kumari","year":"2025","unstructured":"Kumari S, Makarewicz A, Klubo-Gwiezdzinska J. Emerging potential of metabolomics in thyroid Cancer\u2014A. Compr Rev Cancers. 2025;17(6):1017.","journal-title":"Compr Rev Cancers"},{"issue":"9","key":"15073_CR28","doi-asserted-by":"publisher","first-page":"e1120","DOI":"10.1093\/oncolo\/oyae075","volume":"29","author":"J Wang","year":"2024","unstructured":"Wang J, Xu Q, Xuan Z, Mao Y, Tang X, Yang K, et al. Metabolomics reveals the implication of acetoacetate and ketogenic diet therapy in radioiodine-refractory differentiated thyroid carcinoma. Oncologist. 2024;29(9):e1120\u201331.","journal-title":"Oncologist"},{"issue":"1","key":"15073_CR29","doi-asserted-by":"publisher","first-page":"17666","DOI":"10.1038\/s41598-023-41176-4","volume":"13","author":"Z Wang","year":"2023","unstructured":"Wang Z, Yang Y, Xing Y, Si D, Wang S, Lin J, et al. Combined metabolomic and lipidomic analysis uncovers metabolic profile and biomarkers for papillary thyroid carcinoma. Sci Rep. 2023;13(1):17666.","journal-title":"Sci Rep"},{"issue":"1","key":"15073_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/nyas.12956","volume":"1363","author":"SJ Mentch","year":"2016","unstructured":"Mentch SJ, Locasale JW. One-carbon metabolism and epigenetics: understanding the specificity. Ann N Y Acad Sci. 2016;1363(1):91\u20138.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"15073_CR31","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3390\/biom10040568","volume":"10","author":"P Kaiser","year":"2020","unstructured":"Kaiser P. Methionine dependence of cancer. Biomolecules. 2020;10(4):568.","journal-title":"Biomolecules"},{"key":"15073_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-015-0408-1","volume":"13","author":"Y Gu","year":"2015","unstructured":"Gu Y, Chen T, Fu S, Sun X, Wang L, Wang J, et al. Perioperative dynamics and significance of amino acid profiles in patients with cancer. J Translational Med. 2015;13:1\u201314.","journal-title":"J Translational Med"},{"key":"15073_CR33","doi-asserted-by":"publisher","first-page":"RP92707","DOI":"10.7554\/eLife.92707","volume":"12","author":"BJ Wadsworth","year":"2024","unstructured":"Wadsworth BJ, Leiwe M, Minogue EA, Cunha PP, Engman V, Brombach C, et al. A 2-hydroxybutyrate-mediated feedback loop regulates muscular fatigue. Elife. 2024;12:RP92707.","journal-title":"Elife"},{"issue":"2","key":"15073_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell. 2020;38(2):167\u201397.","journal-title":"Cancer Cell"},{"key":"15073_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/B978-0-12-420117-0.00002-5","volume":"122","author":"Y Liu","year":"2014","unstructured":"Liu Y, Hyde AS, Simpson MA, Barycki JJ. Emerging regulatory paradigms in glutathione metabolism. Adv Cancer Res. 2014;122:69\u2013101.","journal-title":"Adv Cancer Res"},{"issue":"8\u20139","key":"15073_CR36","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.clinbiochem.2011.03.025","volume":"44","author":"F Tang","year":"2011","unstructured":"Tang F, Xie C, Huang D, Wu Y, Zeng M, Yi L, et al. Novel potential markers of nasopharyngeal carcinoma for diagnosis and therapy. Clin Biochem. 2011;44(8\u20139):711\u20138.","journal-title":"Clin Biochem"},{"key":"15073_CR37","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s11306-010-0199-6","volume":"6","author":"J-W Kim","year":"2010","unstructured":"Kim J-W, Lee G, Moon S-M, Park M-J, Hong SK, Ahn Y-H, et al. Metabolomic screening and star pattern recognition by urinary amino acid profile analysis from bladder cancer patients. Metabolomics. 2010;6:202\u20136.","journal-title":"Metabolomics"},{"issue":"10","key":"15073_CR38","doi-asserted-by":"publisher","first-page":"e21888","DOI":"10.1096\/fj.202100702R","volume":"35","author":"S Haq","year":"2021","unstructured":"Haq S, Grondin JA, Khan WI. Tryptophan-derived serotonin\u2010kynurenine balance in immune activation and intestinal inflammation. FASEB J. 2021;35(10):e21888.","journal-title":"FASEB J"},{"key":"15073_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-015-0094-9","volume":"3","author":"YW Moon","year":"2015","unstructured":"Moon YW, Hajjar J, Hwu P, Naing A. Targeting the indoleamine 2, 3-dioxygenase pathway in cancer. J Immunother Cancer. 2015;3:1\u201310.","journal-title":"J Immunother Cancer"},{"key":"15073_CR40","doi-asserted-by":"publisher","first-page":"1524651","DOI":"10.3389\/fonc.2024.1524651","volume":"14","author":"I Kang","year":"2025","unstructured":"Kang I, Theodoropoulos G, Wangpaichitr M. Targeting the kynurenine pathway: another therapeutic opportunity in the metabolic crosstalk between cancer and immune cells. Front Oncol. 2025;14:1524651.","journal-title":"Front Oncol"},{"issue":"6","key":"15073_CR41","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3390\/jcm8060842","volume":"8","author":"A Park","year":"2019","unstructured":"Park A, Yang Y, Lee Y, Kim MS, Park Y-J, Jung H, et al. Indoleamine-2, 3-dioxygenase in thyroid cancer cells suppresses natural killer cell function by inhibiting NKG2D and NKp46 expression via STAT signaling pathways. J Clin Med. 2019;8(6):842.","journal-title":"J Clin Med"},{"key":"15073_CR42","first-page":"1170","volume":"20","author":"R Abooshahab","year":"2021","unstructured":"Abooshahab R, Hooshmand K, Razavi F, Dass CR, Hedayati M. A glance at the actual role of glutamine metabolism in thyroid tumorigenesis. EXCLI J. 2021;20:1170.","journal-title":"EXCLI J"},{"issue":"4","key":"15073_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5582\/ddt.2020.03062","volume":"14","author":"T Wang","year":"2020","unstructured":"Wang T, Sun Z, Wang Y, Li F, Zhou X, Tian X, et al. Diagnosis of papillary thyroid carcinoma by 1H NMR spectroscopy-based metabolomic analysis of whole blood. Drug Discov Ther. 2020;14(4):187\u201396.","journal-title":"Drug Discov Ther"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15073-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15073-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15073-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:08:13Z","timestamp":1760526493000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15073-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15073"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15073-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current study adhered to the principles outlined in the Declaration of Helsinki (1975) and was approved by the local Ethics Committee of Shahid Beheshti University of Medical Sciences, Tehran, Iran (IR.SBMU.ENDOCRINE.REC.1402.122). Each participant and healthy volunteer gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1586"}}